↓ Skip to main content

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?

Overview of attention for article published in BMC Cancer, November 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
14 Mendeley
Title
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Published in
BMC Cancer, November 2019
DOI 10.1186/s12885-019-6325-6
Pubmed ID
Authors

Didar Yanardag Acik, Mehmet Bankir, Filiz Alkan Baylan, Bilal Aygun

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 29%
Student > Ph. D. Student 1 7%
Student > Doctoral Student 1 7%
Researcher 1 7%
Professor > Associate Professor 1 7%
Other 0 0%
Unknown 6 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 14%
Medicine and Dentistry 2 14%
Nursing and Health Professions 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Social Sciences 1 7%
Other 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2019.
All research outputs
#20,587,621
of 23,172,045 outputs
Outputs from BMC Cancer
#6,562
of 8,404 outputs
Outputs of similar age
#305,637
of 359,983 outputs
Outputs of similar age from BMC Cancer
#120
of 175 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,404 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,983 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 175 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.